Skip to content
The COVID Project
  1. Library
  2. State health licensing boards
  3. AGY-ST-HEALTH-BOARDS-005

Ex. AGY-ST-HEALTH-BOARDS-005 Order Primary source read

DOH Emergency Order 20-006

In re: Extension of Suspension of Statutes, Rules and Orders, Made Necessary by COVID-19 (pharmacists authorized to order, administer and report COVID-19 tests at licensed pharmacies; Volunteer Health Care Provider Program; ADAP recertification)

Scott A. Rivkees, M.D., State Surgeon General · Florida Department of Health, Office of the State Surgeon General (Board of Pharmacy jurisdiction); State level (Sector regulator)

Open exhibit (PDF, 1.5 MB)Source (opens in a new tab)
The COVID Project

The record

Jurisdiction
Florida Department of Health, Office of the State Surgeon General (Board of Pharmacy jurisdiction); State level · Florida
Level
Sector regulator
Authority
Executive Order 20-52 § 4.B; Fla. Stat. § 252.36(5)(a)
Issued
2020-04-24 Apr. 24, 2020
Effective
2020-04-24
End
Expiration of Executive Order 20-52 (June 26, 2021) (read as 2021-06-26)
In force
Apr. 24, 2020 to June 26, 2021
Quarters
2020 Q22020 Q32020 Q42021 Q12021 Q2
Limitation types
Health care ordersOther
Addressees
  • pharmacists and licensed pharmacies
  • Volunteer Health Care Provider Program providers
  • AIDS Drug Assistance Program applicants
Functions reached
  • DX diagnostics (pharmacies converted to COVID-19 testing sites)
  • SC pharmacy operations
  • HR scope of practice
  • CB patients
Collection
State health licensing boards AGY-ST-HEALTH-BOARDS

Operative words

Section 1: For purposes of preparing for, responding to, and mitigating any effect of COVID-19, I suspend section 483.813, Florida Statutes, for the provision that requires a pharmacist to be separately licensed to perform a clinical laboratory test, and section 465.003(13), Florida Statutes, for the provisions that may prohibit a pharmacist from ordering, administering, or reporting the results of COVID-19 tests, including serology tests, authorized by the United States Food and Drug Administration (FDA), at a location with a clear and active pharmacy license. This suspension applies until the expiration of Executive Order No. 20-52.

Enforcement

Fla. Stat. § 456.072(1)(q); § 465.016 (pharmacist discipline); § 252.50

Notes

Pharmacy testing authorization; runs to June 26, 2021

Retrieval note

Executed April 24, 2020 (clerk stamp Apr. 24, 2020).

A record of The COVID Project. The instrument's text is the source's; the summary fields are The COVID Project's reading of it. Not legal advice.